U.S. Communications Stock News

Corcept Therapeutics (CORT) posted average earnings growth of 5.5% annually over the past five years, with a 5.6% uptick in the most recent year. Revenue is forecast to climb sharply at 28.2% per year, far outpacing the projected 10.4% growth rate for the US market. While net profit margins have dipped to 18.4% from last year’s 21.9%, high earnings quality and robust growth expectations continue to fuel positive investor sentiment despite a premium valuation. See our full analysis for Corcept...

We'd be surprised if Helix Energy Solutions Group, Inc. ( NYSE:HLX ) shareholders haven't noticed that the Executive VP...

ImmunityBio (IBRX) reported another unprofitable period, with losses accelerating at a 15% annual rate over the past five years and net profit margins failing to show improvement. Forecasts suggest the company will remain unprofitable for at least the next three years. However, revenue is projected to surge by 54.9% per year, far outpacing the broader US market's 10.4% average growth rate. Investors now face the challenge of weighing a robust revenue outlook against ongoing losses and high...

Columbus McKinnon Corporation's ( NASDAQ:CMCO ) recent soft profit numbers didn't appear to worry shareholders, as the...

Clarivate Plc ( NYSE:CLVT ) shareholders (or potential shareholders) will be happy to see that the Director, Kenneth...

Orion Group Holdings, Inc. ( NYSE:ORN ) just reported some strong earnings, and the market reacted accordingly with a...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Key Insights The considerable ownership by individual investors in Oncology Institute indicates that they collectively...

Assurant (AIZ) posted a net profit margin of 5.8%, down from last year's 6.9%, while earnings have grown at an average rate of 9.7% annually over the past five years. Market forecasts suggest earnings and revenue will continue to rise at 11.9% and 4.1% per year respectively, both trailing the broader US market’s growth outlook. Shares currently trade at a P/E of 15.4x, above industry and peer averages, but the price remains below an internally estimated fair value, putting the spotlight on...

Adeia Inc. ( NASDAQ:ADEA ) missed earnings with its latest quarterly results, disappointing overly-optimistic...

Key Insights Given the large stake in the stock by institutions, 8x8's stock price might be vulnerable to their trading...

If you’ve ever wondered whether CNX Resources is a bargain or priced for perfection, you’re not alone. Figuring that out is where smart investing starts. Despite a tough year with the stock down 8.3% over the last 12 months, short-term performance is turning around, up 7.1% just this week. Recent news has focused on increased natural gas demand forecasts and shifting analyst sentiment, which are fueling renewed interest in energy stocks like CNX. Momentum from policy changes around domestic...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

The Morning Bull - US Market Morning Update Thursday, Nov, 6 2025 US stock futures are drifting lower this morning as investors weigh a jump in long-term bond yields and a new record for household debt. The prospect of higher borrowing costs and elevated debt levels is spurring fresh caution across the market and putting pressure on consumer-focused stocks, as investors focus on the risk that financial strain could temper the economy’s momentum. Act now to uncover undervalued stocks based on...

The subdued stock price reaction suggests that Envista Holdings Corporation's ( NYSE:NVST ) strong earnings didn't...

AES (AES) posted earnings growth of 9.7% over the past year, a step down from its striking 56.4% per year average over the past five years. Net profit margins improved to 7.6%, compared to 6.7% a year earlier. Shares currently trade at $14.22, notably below the estimated fair value of $19.28. With the company’s Price-To-Earnings ratio of 11x standing well below sector averages, investors will likely weigh discounted valuation against questions around the sustainability and quality of recent...

SNDL (NasdaqCM:SNDL) has released its third quarter and nine month earnings for 2025, revealing higher sales and a narrower net loss compared to the same periods last year. These updates are sparking fresh investor interest. See our latest analysis for SNDL. SNDL’s share price has been on a rollercoaster this year. After a rally earlier in the quarter, it’s taken a breather with a 27.7% drop over the past month and a 14.4% fall in the last week, despite the latest earnings showing meaningful...

Stem, Inc.'s ( NYSE:STEM ) solid earnings report last week was underwhelming to investors. We think that they may be...

Rani Therapeutics Holdings (RANI) just made headlines with a new licensing agreement with Chugai Pharmaceutical. This deal brings over $1 billion in potential revenue for its RaniPill technology and boosts its financial flexibility. See our latest analysis for Rani Therapeutics Holdings. Momentum around Rani Therapeutics Holdings has accelerated sharply, with a 1-month share price return of nearly 400% and year-to-date gains over 70%. This reflects investor excitement after its Chugai deal...

Shareholders appeared unconcerned with Columbia Sportswear Company's ( NASDAQ:COLM ) lackluster earnings report last...

It's not a stretch to say that Natural Health Trends Corp.'s ( NASDAQ:NHTC ) price-to-sales (or "P/S") ratio of 0.9x...

Investors were disappointed with Riot Platforms, Inc.'s ( NASDAQ:RIOT ) earnings, despite the strong profit numbers. We...

Insiders who bought US$337.9k worth of Magnachip Semiconductor Corporation's ( NYSE:MX ) stock at an average buy price...

MiMedx Group, Inc.'s ( NASDAQ:MDXG ) stock was strong despite it releasing a soft earnings report last week. We think...